Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails – Xconomy
Xconomy |
Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails
Xconomy AstraZeneca disclosed this morning that a combination of two of its immunotherapy drugs, durvalumab (Imfinzi) and tremelimumab, failed to best chemotherapy at keeping patients’ lung cancers from spreading, one of the main goals of the Mystic trial. Bristol-Myers slides with Wall St eyeing key cancer drugFinancial Times Bristol-Myers shares slump after failed AstraZeneca drug trialReuters Bristol-Myers shares fall after failed AstraZeneca drug trialNasdaq |
|
Sarepta Therapeutics Announces its Partner, Genethon, Published New Micro-Dystrophin Gene Therapy Data in …
Nasdaq “While early, these data highlight the potential for Genethon’s micro-dystrophin gene therapy program and once again underscore the significance of dystrophin production in the treatment of DMD,” said Douglas Ingram, Sarepta’s president and chief … |
Curetoday.com |
Patients’ Gray Hair Turns Dark After Immunotherapy for Lung Cancer
Curetoday.com The study, which was published in JAMA Dermatology, examined 14 patients who have non-small cell lung cancer (NSCLC) and were receiving immunotherapy treatments including one of the following agents: Opdivo (nivolumab), Keytruda (pembrolizumab) … |
|
CRISPR, Star Trek-Like Testing Devices, and Antibiotic Resistance a Focus at Clinical Diagnostics Convention …
PR Newswire (press release) ROCKVILLE, Md., July 27, 2017 /PRNewswire/ — Say it three times fast: “Clustered regularly interspaced short palindromic repeats” —Or better known as CRISPR. This gene-editing technology will be a key feature of the world’s largest gathering of lab … |
|
Two Gene Therapy Approaches Pending Approval from FDA Bring Hope to Mesothelioma Community
MesotheliomaHelp.org (blog) Nearly five years ago, MesotheliomaHelp reported about a breakthrough treatment called gene therapy. At the time, it was touted as the “next frontier” in medicine, and cancer patients from around the world watched closely in the hopes that the … |
|
Two Gene Therapy Approaches Pending Approval from FDA Bring Hope to Mesothelioma Community
MesotheliomaHelp.org (blog) Nearly five years ago, MesotheliomaHelp reported about a breakthrough treatment called gene therapy. At the time, it was touted as the “next frontier” in medicine, and cancer patients from around the world watched closely in the hopes that the … |